An international transplant patient can bring in as much as $2 million — far more than a U.S. patient paying through private insurance or a public program like Medicare.
Source: New York Times
An international transplant patient can bring in as much as $2 million — far more than a U.S. patient paying through private insurance or a public program like Medicare.
Source: New York Times
The following was reported in Kaiser Family Foundation Health News:
Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a Thursday directive from the Trump administration.
President Trump wants to bring back drug manufacturing to the United States. Yet, he is unlikely to do so to any significant degree. About 90% of the drugs Americans take are generic drugs. Generic drugs are those that have lost patent protection. The profit margins on generic drugs are slim, and competition is often fierce.